Concentra Group Holdings Parent, Inc. CON 深 沪
已收盘 07-02 16:00:00 美东时间
31.91
+1.140
+3.70%
华盛通- 最 高31.93
- 今 开30.90
- 成交量 127.05万股
- 最 低 30.85
- 昨 收 30.77
- 总市值 408.33万
- 52周最高 31.93
- 市盈率 静 24.94
- 换手率 0.99%
- 52周最低 18.3575
- 委 比 0.00%
- 总股本 0.00亿
- 历史最高 31.93
- 量 比 0.76
- 振 幅 3.51%
- 历史最低 18.3575
- 每 手 1
- 风险率 2.50%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Concentra Standout in Occupational Medicine: Analyst
William Blair on Wednesday initiated coverage on Concentra Group Holdings Parent Inc. (NYSE:CON), citing that the company is taking care of business. Concentra is a US health care company specializing in occupational medicine, urgent care, and physical therapy. Analyst Sees Premium Valuation As Just...
07-02 01:55
William Blair Initiates Coverage On Concentra Group Holdings with Outperform Rating
William Blair analyst Jared Haase initiates coverage on Concentra Group Holdings (NYSE:CON) with a Outperform rating.
07-02 00:15
美股大行评级 | Ciena、Rubrik获多家大行上调目标价；库珀医疗、Guidewire软件、露露乐蒙等遭多家大行下调目标价
今日重点评级关注：瑞银：维持DraftKings"买入"评级，目标价从43美元升至49美元；Needham：维持Planet Labs"买入"评级，目标价从40美元升至53美元
06-08 11:33
Goldman Sachs Initiates Coverage On Concentra Group Holdings with Buy Rating, Announces Price Target of $30
Goldman Sachs analyst Scott Fidel initiates coverage on Concentra Group Holdings (NYSE:CON) with a Buy rating and announces Price Target of $30.
06-05 20:14
美股大行评级 | Arxis、Madison Air获多家大行首予买入评价！潜在涨幅441.87%！Caribou Biosciences获HC Wainwright & Co.升目标价至11美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从9美元升至11美元；康托·菲茨杰拉德：维持Artiva Biotherapeutics"超配"评级，目标价从10美元升至40美元
05-12 12:36
Truist Securities Reiterates Buy on Concentra Group Holdings, Raises Price Target to $31
Truist Securities analyst David Macdonald reiterates Concentra Group Holdings (NYSE:CON) with a Buy and raises the price target from $29 to $31.
05-11 22:43
美股大行评级 | 最高582美元！博通获多家机构上调目标价；GENI、Okta、Rigetti Computing、Veeva Systems、Wix.com遭多家机构下调目标价
今日重点评级关注：韦德布什：维持TScan Therapeutics"跑赢大市"评级，目标价从4美元升至5美元；HC Wainwright & Co.：维持莱斯康制药"买入"评级，目标价从4美元升至6美元
03-06 11:58
Concentra Group Holdings Sees FY2026 Sales $2.250B-$2.350B vs $2.318B Est
Concentra Group Holdings (NYSE:CON) sees FY2026 sales of $2.250 billion-$2.350 billion vs $2.318 billion analyst estimate.
02-27 05:32
Concentra Group Holdings Q4 Earnings Report: What Investors Need to Know
Concentra Group Holdings (NYSE:CON) just disclosed its Q4 earnings on Thursday,...
02-27 05:32
Earnings Scheduled For February 26, 2026
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
